MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Abbott Laboratories

Ouvert

SecteurSoins de santé

128.23 -1

Résumé

Variation du prix de l'action

24h

Actuel

Min

127.11

Max

130.1

Chiffres clés

By Trading Economics

Revenu

7.6B

9.2B

Ventes

339M

11B

P/E

Moyenne du Secteur

17.001

57.333

BPA

1.09

Rendement du dividende

1.8

Marge bénéficiaire

84.099

Employés

114,000

EBITDA

82M

3B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+11.42% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.80%

2.63%

Date du Prochain Dividende

15 mai 2025

Date du Prochain Détachement de Dividende

14 juil. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

3B

225B

Ouverture précédente

129.23

Clôture précédente

128.23

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Abbott Laboratories Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

16 avr. 2025, 16:21 UTC

Résultats

Abbott Labs Bracing for Tariffs as Profits Rise -- Update

16 avr. 2025, 12:14 UTC

Résultats

Abbott Labs 1Q Profit Jumps on Gains in Nutrition, Medical Devices

22 janv. 2025, 19:03 UTC

Résultats

Correction to Abbott Labs 4Q Sales Just Miss Estimates Article

22 janv. 2025, 18:20 UTC

Résultats

Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update

22 janv. 2025, 12:45 UTC

Résultats

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

16 avr. 2025, 15:09 UTC

Market Talk

Abbott Says Tariffs Killed Chances of an Outlook Raise -- Market Talk

16 avr. 2025, 14:17 UTC

Résultats

Abbott Laboratories Stock Rises as First-Quarter Earnings Surpass Expectations -- Barrons.com

16 avr. 2025, 11:34 UTC

Résultats

Abbott Labs 1Q Gross Margin of 52.8 % of Sales; Adj Gross Margin of 57.1 % >ABT

16 avr. 2025, 11:33 UTC

Résultats

Abbott Labs Projects FY25 Adj Operating Margin to Be 23.5% to 24.0% of Sales >ABT

16 avr. 2025, 11:32 UTC

Résultats

Abbott Labs Backs FY25 Adj EPS $5.05-Adj EPS $5.25 >ABT

16 avr. 2025, 11:32 UTC

Résultats

Abbott Labs Sees 2Q Adj EPS $1.23-Adj EPS $1.27 >ABT

16 avr. 2025, 11:31 UTC

Résultats

Abbott Labs Projects FY25 Organic Sales Growth of 7.5% to 8.5% >ABT

16 avr. 2025, 11:30 UTC

Résultats

Abbott Reaffirms Full-Yr Guidance

16 avr. 2025, 11:30 UTC

Résultats

Abbott Labs 1Q Organic Sales Growth Up 6.9% >ABT

16 avr. 2025, 11:30 UTC

Résultats

Abbott Labs 1Q Sales $10.36B >ABT

16 avr. 2025, 11:30 UTC

Résultats

Abbott Labs 1Q Net $1.33B >ABT

16 avr. 2025, 11:30 UTC

Résultats

Abbott Labs 1Q EPS 76c >ABT

16 avr. 2025, 11:30 UTC

Résultats

Abbott Labs 1Q Adj EPS $1.09 >ABT

16 avr. 2025, 09:57 UTC

Actions en Tendance

Stocks to Watch: Nvidia, AMD, Heineken, ASML -- WSJ

1 févr. 2025, 18:14 UTC

Actualités

Musk's X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit -- WSJ

22 janv. 2025, 16:40 UTC

Actualités
Résultats

Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. -- Barrons.com

22 janv. 2025, 15:20 UTC

Résultats

Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine -- IBD

22 janv. 2025, 15:08 UTC

Résultats

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 janv. 2025, 13:51 UTC

Résultats

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit -- IBD

22 janv. 2025, 13:39 UTC

Actualités
Résultats

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 janv. 2025, 12:02 UTC

Résultats

Abbott Labs Sees 1Q Adj EPS $1.05-Adj EPS $1.09 >ABT

22 janv. 2025, 12:01 UTC

Résultats

Abbott Labs Sees 2025 Adj EPS $5.05-Adj EPS $5.25 >ABT

22 janv. 2025, 12:01 UTC

Résultats

Abbott Labs Sees 2025 Adjusted Operating Margin 23.5%-24% >ABT

22 janv. 2025, 12:00 UTC

Résultats

Abbott Labs Sees 2025 Organic Sales Growth 7.5%-8.5% >ABT

22 janv. 2025, 12:00 UTC

Résultats

Abbott Labs 4Q Net $9.23B >ABT

Comparaison

Variation de prix

Abbott Laboratories prévision

Objectif de Prix

By TipRanks

11.42% hausse

Prévisions sur 12 Mois

Moyen 144.15 USD  11.42%

Haut 159 USD

Bas 127 USD

Basé sur 21 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

21 ratings

18

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

128.52 / 129.7Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.